Carregant...
Long-term follow up study of community based patients receiving XR-NTX for Opioid Use Disorders
BACKGROUND AND OBJECTIVES: Extended-release naltrexone (XR-NTX) is FDA-approved to prevent relapse in patients with Opioid Use Disorder. However little is known about long-term use among community-based outpatients. METHODS: Retrospective chart review and long-term follow-up survey among individuals...
Guardat en:
| Publicat a: | Am J Addict |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5426981/ https://ncbi.nlm.nih.gov/pubmed/28328148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajad.12527 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|